The upregulation of UCA1 occurs upon inactivation of its transcription repressor C/EBPα (CCAAT/enhancer-binding protein α), which is mutated in AML, resulting in the expression of a dominant negative isoform (C/EBPα -p30) capable of inducing UCA1 expression [199]. This evidence concerns the gene CEBPA and acute myeloid leukemia.